Cogent Biosciences (COGT) Treasury Shares (2017 - 2022)

Cogent Biosciences (COGT) has reported Treasury Shares for 9 consecutive years, with $539000.0 the latest figure, recorded in Q4 2025.

• In Q4 2025, Treasury Shares rose 573.75% year-over-year to $539000.0; the TTM figure through Dec 2025 stood at $539000.0 (up 573.75% YoY), while the FY2025 annual figure was $4.0 million, up 47.02% from the prior year.
• Treasury Shares rose to $539000.0 in Q4 2025 per COGT's latest filing, from $80000.0 in the prior quarter.
• Across five years, Treasury Shares topped out at $2.5 million in Q4 2023 and bottomed at $80000.0 in Q4 2024.
• Historically, Treasury Shares has averaged $454754.5 across 5 years, with a median of $103289.0 in 2021.
• Annual changes were most pronounced in 2024 — Treasury Shares tumbled 96.8% — and 2025, when it surged 573.75%.
• Cogent Biosciences' Treasury Shares stood at $103289.0 in 2021, then retreated by 7.7% to $95334.0 in 2022, then soared by 2522.36% to $2.5 million in 2023, then sank by 96.8% to $80000.0 in 2024, then soared by 573.75% to $539000.0 in 2025.
• Business Quant data shows COGT's Treasury Shares at $539000.0 in Q4 2025, $80000.0 in Q4 2024, and $2.5 million in Q4 2023.